Stephen Ezell

Stephen Ezell
Vice President, Global Innovation Policy
Information Technology and Innovation Foundation
Phone: 
202-449-1349

Stephen Ezell is vice president, global innovation policy, at the Information Technology and Innovation Foundation (ITIF). He focuses on science and technology policy, international competitiveness, trade, manufacturing, and services issues.

He is the coauthor of Innovating in a Service-Driven Economy: Insights, Application, and Practice (Palgrave Macmillan, 2015) and Innovation Economics: The Race for Global Advantage (Yale, 2012).

Ezell comes to ITIF from Peer Insight, an innovation research and consulting firm he cofounded in 2003 to study the practice of innovation in service industries. At Peer Insight, Ezell led the Global Service Innovation Consortium, published multiple research papers on service innovation, and researched national service innovation policies being implemented by governments worldwide.

Prior to forming Peer Insight, Ezell worked in the New Service Development group at the NASDAQ Stock Market, where he spearheaded the creation of the NASDAQ Market Intelligence Desk and the NASDAQ Corporate Services Network, services for NASDAQ-listed corporations. Previously, Ezell cofounded two successful innovation ventures, the high-tech services firm Brivo Systems and Lynx Capital, a boutique investment bank.

Ezell holds a B.S. from the School of Foreign Service at Georgetown University, with an honors certificate from Georgetown’s Landegger International Business Diplomacy program.

Recent Publications

July 21, 2021

Four out of five Americans say prescription drug prices are unreasonably high, according to a recent KFF survey—and people across the political spectrum say pharma profits are a major contributing factor.

July 12, 2021

Few would oppose the president’s stated goals of lowering prices, raising wages, and increasing convenience for Americans. But his executive order is not the way to achieve them.

May 20, 2021

In her sensationally titled report, “Killer Profits: How Big Pharma Takeovers Destroy Innovation and Harm Patients,” the deputy chair of the Congressional Progressive Caucus issued an ideologically inspired jeremiad grounded in assertions that are easily refuted with data.

May 14, 2021

Throughout 2021, stories have dominated headlines of a chip, or semiconductor, 

April 29, 2021

From vaccines and therapeutics to delivery robots, intellectual property has played an indispensable role in facilitating development of a range of inventive products that have helped address health care, work, and social challenges brought on by the pandemic.

April 19, 2021

Blood-based multi-cancer early detection (MCED) technologies hold the promise to revolutionize America’s cancer-screening paradigm, dramatically expanding the range of detectable cancers and identifying them at earlier stages when cancers are more treatable. Policymakers should provide a supportive regulatory and coverage environment.

April 16, 2021

U.S. policymakers must recognize the pivotal role Taiwan plays in America’s East Asian security framework, and pursue a range of policies designed to deepen the economic, innovation, trade and security linkages between the two allies.

April 12, 2021

As technology and industry strategy experts, we commend Congress and the Biden administration for focusing on ensuring U.S. advanced technology competitiveness. Toward that end, we offer a number of recommendations for further action.

April 9, 2021

The United States and other developed, democratic societies have a moral obligation to ensure the world’s citizens receive COVID-19 vaccines and therapeutics. But there is absolutely no need to abrogate IP rights to fulfill that objective.

March 31, 2021

President Biden’s American Jobs Plan proposes many laudable and much-needed investments and programmatic improvements to America’s innovation system. But they will only succeed if they are part of a holistic approach that’s complemented by other equally necessary policies, such as investments in workforce training and STEM education, and maintaining robust IP protections.

March 9, 2021

Amidst an unprecedented pace of innovation, some 90 developing nations, led by India and South Africa, have petitioned the WTO’s TRIPS Council calling for a waiver to suspend all IP rights associated with COVID-19 innovations—again asserting the false narrative that IP rights inhibit access to medicines.

February 18, 2021

China’s mercantilist strategy to grab market share in the global semiconductor industry is fueling the rise of inferior innovators at the expense of superior firms in the United States and other market-led economies. That siphons away resources that would otherwise be invested in the virtuous cycle of cutting-edge R&D that has driven semiconductor innovation for decades.

Recent Events and Presentations

June 30, 2021

ITIF hosted an expert panel discussion exploring the implications of GTIPA’s declaration of principles, and prospects for the vision to become a reality.

June 29, 2021

ITIF, Brookings, and AMCC hosted a special, live discussion with senior White House and Congressional offices as well as leading think tanks for a comprehensive overview of these legislative proposals and their potential to stimulate American manufacturing leadership.

June 12, 2021

Stephen Ezell gave a keynote presentation to the Alpha-1 Foundation 2021 Annual Conference addressing policy priorities to ensure continued American life-sciences innovation leadership.

June 10, 2021

Watch our overview of this research, including sectoral analysis of five advanced industries: telecommunications equipment, biopharmaceuticals, solar photovoltaics, semiconductors, and high-speed rail. ITIF analysts will discuss how Chinese policies affect global innovation and steps allied nations can take to mitigate the harm.

May 24, 2021

ITIF and Geneva Network hosted a discussion on the role of IP rights in vaccine and therapeutic R&D, manufacturing, and preparedness for future pandemics. Panelists from around the world will discuss the best ways to scale up mass vaccine and therapeutic manufacturing and examine the implications that would arise from a global waiver of IP rights.

April 29, 2021

ITIF hosted an expert panel discussion about the report and the vital role IP has played throughout the pandemic.

April 21, 2021

ITIF hosted an expert panel discussion exploring the groundbreaking innovations and policy considerations impacting the field of multi-cancer early detection.

March 25, 2021

ITIF and the Bayh-Dole Coalition hosted a joint video webinar that will clarify the provision’s intent and explain once and for all how Bayh-Dole’s march-in right can and cannot be used.

February 18, 2021

Stephen Ezell and Jaci McDole presented about Intellectual Property’s Impact on Global Health and Life-sciences Innovation to students at the University of Akron Law School on February 18, 2021.

February 12, 2021

Stephen Ezell presented to the UN Commission on Social Development on Lessons Learned from the Use of Digital Technologies to Promote Healthy Aging in the Era of COVID-19.

December 16, 2020

ITIF hosted a discussion on this critical issue. The event featured a keynote address by Simon Tripp of TEConomy Partners, author of the new report “Response and Resilience: Lessons Learned from Global Life Sciences Ecosystems in the COVID-19 Pandemic,” followed by an expert panel of respondents.

November 17, 2020

ITIF hosted a two-part forum on innovative state-level manufacturing policies.